Case Study: The Institute of Cancer Research advances cancer drug discovery with Stratasys J5 MediJet 3D printing

The Institute of Cancer Research advances cancer drug discovery with Stratasys J5 MediJet after discovering 20+ drug candidates

The Institute of Cancer Research faced the challenge of visualizing complex, flexible protein structures within cancer cells to aid in drug discovery. Their legacy 3D printing technology could only produce simplified, rigid models with poor resolution, which limited researchers' ability to design effective drug compounds. To overcome this, they utilized a Stratasys J5 MediJet 3D printer.

Stratasys provided a solution with the J5 MediJet, which enabled the creation of a first-of-its-kind, highly detailed model that accurately depicts a protein being targeted by novel drugs. This allowed researchers to visually design drug compounds that fit into the protein's structure to stop the cancer cell from replicating. The implementation of this Stratasys technology helps equip the next generation of cancer researchers and supports the institute's world-leading success in discovering new cancer treatments.

The Institute of Cancer Research